FDA approves Trudhesa nasal spray for the treatment of acute migraine – Impel Neuropharma
Impel NeuroPharma, Inc. announced that the FDA approved Trudhesa (dihydroergotamine mesylate) nasal spray (0.725 mg per spray) for the acute treatment of migraine with or without aura in… read more.